Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2012
12/04/2012US8323897 Multiplex amplification of polynucleotides
12/04/2012US8323896 Epidermal growth factor (EGF) expression and/or polymorphisms thereof for predicting the risk of developing cancer
12/04/2012US8323895 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide
12/04/2012US8323894 Methods of analysis of allelic imbalance
12/04/2012US8323893 Administration of exogenous miRNA or siRNA
12/04/2012US8323892 Hybridization method and apparatus
12/04/2012US8323891 miRNA triplex formations for the downregulation of viral replication
12/04/2012US8323890 Process for high-throughput DNA methylation analysis
12/04/2012US8323889 Process for the production of an abuse-proofed solid dosage form
12/04/2012US8323888 Nanoparticles having oligonucleotides attached thereto and uses therefor
12/04/2012US8323887 Miniaturized fluid delivery and analysis system
12/04/2012US8323886 Fluorescence methods of detecting a protein-elongation related complex and corollary sequence information
12/04/2012US8323885 Using allelic variation aristaless homeobox gene (ARX) as diagnostic tool in detection of convulsive and learning disorders
12/04/2012US8323884 Isolated SNARE YKT6 genomic polynucleotide fragments from chromosome 7 and their uses
12/04/2012US8323882 Method and system for the analysis of high density cells samples
12/04/2012US8323660 Method for identification, isolation and production of antigens to a specific pathogen
12/04/2012US8323641 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/04/2012US8323637 Synthetically functionalized living cells
12/04/2012CA2656688C Low-mass sample block with rapid response to temperature change
12/04/2012CA2635001C High quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation
12/04/2012CA2631316C Sequencing and genotyping using reversibly 2'-modified nucleotides
12/04/2012CA2554776C Test strip composition and method to measure cholesterol from low density lipoproteins
12/04/2012CA2484554C Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media
12/04/2012CA2443345C Disease-associated protein
12/04/2012CA2430582C A method for in vitro molecular evolution of protein function
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2410956C Three-dimensional skin model
12/04/2012CA2349442C Compositions and methods for wt1 specific immunotherapy
12/04/2012CA2222509C Connective tissue growth factor
11/2012
11/29/2012WO2012162660A2 Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies
11/29/2012WO2012162647A1 Compositions and methods for screening for creatine transporter deficiency
11/29/2012WO2012162621A1 Methods for suppression pcr
11/29/2012WO2012162613A2 Detection of sequence variants in the human epidermal growth factor receptor (egfr) gene
11/29/2012WO2012162594A1 Methods of determining vaccination efficacy, devices, and compositions related thereto
11/29/2012WO2012162563A2 Method for exosomal biomarker detection by electric field-induced release and measurement
11/29/2012WO2012162535A1 Use of phosphatase inhibitors or histone deacetylase inhibitors to treat diseases characterized by loss of protein function
11/29/2012WO2012162514A2 Epigenetic co-repressors of the gamma-globin gene and methods of using same
11/29/2012WO2012162466A1 Microbicidal compositions and methods of production use thereof
11/29/2012WO2012162460A2 Genes dysregulated in autism as biomarkers and targets for therapeutic pathways
11/29/2012WO2012162429A2 Dna sequencing by synthesis using raman and infrared spectroscopy detection
11/29/2012WO2012162394A2 Compositions and methods for treating renal disease
11/29/2012WO2012162324A2 Method of diagnosing and treating an aspergillus species-associated condition
11/29/2012WO2012162291A1 Compositions and methods for modulating the activity of epstein-barr nuclear antigen 1
11/29/2012WO2012162267A2 Nucleic acid encoding reactions
11/29/2012WO2012162260A2 Transgenic biosensors
11/29/2012WO2012162247A2 Monitoring systems for biomass processing systems
11/29/2012WO2012162181A2 Analysis and sorting of motile cells
11/29/2012WO2012162179A1 Tau protease compositions and methods of use
11/29/2012WO2012162161A1 Microsporidia detection system and method
11/29/2012WO2012162139A1 Method to estimate age of individual based on epigenetic markers in biological sample
11/29/2012WO2012162049A2 Methods and compositions for measuring radiation exposure in a subject
11/29/2012WO2012161992A1 Salmonella detection articles and methods of use
11/29/2012WO2012161938A1 Clozapine immunoassay
11/29/2012WO2012161803A1 Analyzing the fmr1 gene
11/29/2012WO2012161688A1 Sulfotransferase assay
11/29/2012WO2012161502A2 Manufacturing method for silica encapsulated single-enzyme nanoparticles and single-enzyme nanoparticles mannufactured by means of method
11/29/2012WO2012161385A1 Information providing method for diagnosing cancer using real-time polymerase chain reaction and cancer diagnostic kit therefor
11/29/2012WO2012161227A1 Nucleic acid construct, nucleic acid-protein complex, and use thereof
11/29/2012WO2012161143A1 Clarifying reagent for biological materials and use thereof
11/29/2012WO2012161124A1 Composition containing micro rna or expression system thereof
11/29/2012WO2012161117A1 Primer set for identification of cytomegalovirus genome
11/29/2012WO2012160551A2 Methods and compositions for determining heart failure or a risk of heart failure
11/29/2012WO2012160519A2 Diagnostic method for determining the aggressive and prognosis of papillary thyroid cancer
11/29/2012WO2012160517A1 Bilirubin oxidase from magnaporthe oryzae and applications thereof
11/29/2012WO2012160393A1 Microcantilever sensor with bimorph actuation and piezoresistive read - out
11/29/2012WO2012160278A1 Universal primers and the use thereof for the detection and identification of amphibia/fish species
11/29/2012WO2012160277A1 Universal primers and the use thereof for the detection and identification of vertebrate species
11/29/2012WO2012160235A1 Genome fingerprint for predicting the clinical response to anti-tumor therapy in colorectal cancer
11/29/2012WO2012160184A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012160183A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012160177A1 Biomarkers for lung cancer
11/29/2012WO2012160091A2 Sensor device for detecting an analyte
11/29/2012WO2012160083A1 Multiplexed proximity ligation assay
11/29/2012WO2012160031A1 Method for prognosing solid tumor outcome
11/29/2012WO2012159820A1 Automated ctc detection
11/29/2012WO2012159768A1 Compositions and methods for detection of staphylococcus aureus
11/29/2012WO2012159754A2 Individualized vaccines for cancer
11/29/2012WO2012159643A1 Individualized vaccines for cancer
11/29/2012WO2012159564A1 High throughput methylation detection method
11/29/2012WO2012159263A1 Enzyme-degradable polymer and application thereof
11/29/2012WO2012159262A1 Selective glycosidase inhibitors and uses thereof
11/29/2012WO2012139089A3 Fungal-derived carbohydrate-conjugated scaffold
11/29/2012WO2012139046A3 Signal amplification methods for the imaging of protein synthesis and neurotransmitter transport
11/29/2012WO2012135714A3 Serine biosynthesis pathway inhibition for treatment of cancer
11/29/2012WO2012134063A3 Primer for detecting pathogenic bacteria of oral bacterial infectious diseases, and use thereof
11/29/2012WO2012125623A3 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
11/29/2012WO2012122314A3 Rapid cell purification systems
11/29/2012WO2012122236A3 Method and system to detect and diagnose alzheimer's disease
11/29/2012WO2012116220A3 Materials and methods for detection of hpv nucleic acid
11/29/2012WO2012107778A3 Mutant pores
11/29/2012WO2012107530A8 Combination of biomarkers for detecting and evaluating a hepatic fibrosis
11/29/2012WO2012090073A3 Methods and compositions for predicting chemotherapy sensitivity
11/29/2012WO2012083004A3 Blood-borne mirnas as surrogate markers of drug efficacy for cardiac conditions
11/29/2012WO2012081856A3 Method for preparing nucleic acid probe-coated porous solid support strip
11/29/2012WO2012075069A3 Signatures and determinants associated with cancer and methods of use thereof
11/29/2012WO2012019200A3 Assay systems for determination of source contribution in a sample
11/29/2012WO2011070441A3 Categorization of dna samples
11/29/2012WO2006091470A8 Improved halohydrin dehalogenases and related polynucleotides
11/29/2012US20120304331 Herbicide tolerant soybean plants and methods for identifying same
11/29/2012US20120304330 Elite event ee-gm3 and methods and kits for identifying such event in biological samples